-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | 0,60 % | 0,00 % | -16,00 % | 7,01 % | -40,00 % | -16,21 % | - |
Larimar Therapeutics Inc. | -2,63 % | -8,07 % | 23,33 % | -61,56 % | -20,43 % | 80,49 % | -68,03 % |
Vaxart Inc. | -1,80 % | -18,49 % | -22,28 % | -51,38 % | -56,32 % | -91,60 % | -96,34 % |
News

Huntsman (HUN) Q2 Revenue Falls 7.4%
Huntsman (NYSE:HUN), the global specialty chemicals company serving industries from construction to transportation, reported its financial results for the second quarter on July 31, 2025. The

Is Nebius Stock A Buy Before Aug. 7?
Throughout 2025, a number of data center stocks have emerged beyond the incumbent players such as Nvidia and Advanced Micro Devices. One company that's witnessed a significant rise in popularity is

Is It Too Late to Buy AMD Stock?
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.